Neurology Devices Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Neurology Devices Market by Product (Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices) By End User (Hospitals, Ambulatory surgery centers, Neurology clinics) and By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Neurology Devices Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product, end user and region. This report studies global neurology devices market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global neurology devices market report includes human demographics; and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include, marketers, policymakers, and cold plasma service providers engaged. Neurological devices can help analyze, forestall, and treat an assortment of neurological issue and conditions, for example, Alzheimer’s sickness, Parkinson’s infection, significant dejection, epilepsy, spinal string damage, and horrendous mind damage. Neurological devices can be utilized to help reestablish hearing and locate and give expanded capacity to those with appendage misfortune or intrinsic appendage contrasts. Cases of neurological devices incorporate neurodiagnostics, neurointerventional, and neurostimulation devices. The expanding financing for R&D in the market will be one of the most recent patterns that will pick up footing in the interventional neurology devices market amid the following four years. The expanding subsidizing by government into R&D tasks and joint effort of government and non-government offices will support the market development.

Neurology Devices Market

MARKET SUMMARY
-
x
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR–X%
  • Largest Market– North America
  • Fastest Growing- Asia Pacific

Neurology Devices Market

  • Neurology Devices Market is expanding at a significant CAGR over 2022 to 2028 during the forecast period.
  • Players focusing on innovation of newer techniques and collaboration strategies to retain market position in global Neurology Devices Market
  • The activities taken by these organizations are giving a chance to producers to grow innovatively propelled gadgets for the early determination of wounds identified with mind issue, such activities by makers will push the market development.
Market Leaders
  • Johnson & Johnson (U.S.)
  • MicroPort Scientific Corporation (China)
  • Medtronic plc (Ireland)
  • Penumbra, Inc. (U.S.)
  • Terumo Corporation (Japan)
  • Merit Medical Systems, Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • L. Gore & Associates, Inc. (U.S.),
Neurology Devices Market

Drivers and Restraints

Due of cutting edge advancements in neurostimulation and neuromodulation systems, the organizations are likewise associated with the presentation and change of attractive incitement innovation. Improvement of calculations for speedier and proficient answers for infection determination and treatment are relied upon to support division development all through the figure time frame.Market players are associated with mergers with the littler elements and research organizations keeping in mind the end goal to upgrade their quality and help being developed of cutting edge and additionally safe and solid methods.


Neurology Devices Market Regional Analysis

North America dominates the market

North America commands the market and is required to hold the biggest piece of the overall industry because of the noteworthy appropriation of neurovascular gadgets among neurosurgeons, great repayment situation, high nearness of gadget makers in the district, and accessibility of critical R&D speculations. Asia-Pacific is the quickest developing district of the market, attributable to components, for example, the nearness of a substantial patient populace base for target ailments, rising mindfulness among neurosurgeons identified with the advantages offered by interventional neurology gadgets, continuous government activities to modernize and extend medicinal services foundation, and expanding appropriation of neurovascular gadgets because of diminishing item cost inferable from progressively limited assembling and fortifying of conveyance systems.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis
Neurology Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Neurology Devices Market Introduction
2.1. Global Neurology Devices Market – Taxonomy
2.2. Global Neurology Devices Market –Definitions
2.2.1. By Product
2.2.2. By End User
2.2.3. By Region
3. Global Neurology Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Neurology Devices Market Dynamic Factors – Impact Analysis
3.6. Global Neurology Devices Market – Competition Landscape
4. Global Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Neurology Devices Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
5.1. Neurostimulation Devices
5.1.1. Spinal Cord Stimulation Devices
5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Deep Brain Stimulation Devices
5.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Sacral Nerve Stimulation Devices
5.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Other Neurostimulation Devices
5.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Neurosurgery Devices
5.2.1. Neuroendoscopes
5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Stereotactic Systems
5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Aneurysm Clips
5.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.2.4. Other Neurosurgery Devices
5.2.4.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.4.3. Market Opportunity Analysis
5.3. Interventional Neurology Devices
5.3.1. Interventional/Surgical Simulators
5.3.1.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Neurothrombectomy Devices
5.3.2.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
5.3.3. Carotid Artery Stents
5.3.3.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.3.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3.3. Market Opportunity Analysis
5.3.4. Embolic Coils
5.3.4.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.3.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.4.3. Market Opportunity Analysis
5.3.5. Support Devices
5.3.5.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.3.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.5.3. Market Opportunity Analysis
5.4. Cerebrospinal Fluid Management Devices
5.4.1. CSF Shunt Devices
5.4.1.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. CSF Drainage Devices
5.4.2.1. Market Analysis, 2017-2021  and Forecast, 2022 -2028 (Revenue, USD Mn)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
6. Global Neurology Devices Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
6.1. Hospitals
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Ambulatory surgery centers
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Neurology clinics
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Neurology Devices Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Neurology Devices Market – Opportunity Analysis Index, By Product, By Application and Region, 2022 – 2028
8. North America Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
8.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Neurostimulation Devices
8.1.1.1. Spinal Cord Stimulation Devices
8.1.1.2. Deep Brain Stimulation Devices
8.1.1.3. Sacral Nerve Stimulation Devices
8.1.1.4. Other Neurostimulation Devices
8.1.2. Neurosurgery Devices
8.1.2.1. Neuroendoscopes
8.1.2.2. Stereotactic Systems
8.1.2.3. Aneurysm Clips
8.1.2.4. Other Neurosurgery Devices
8.1.3. Interventional Neurology Devices
8.1.3.1. Interventional/Surgical Simulators
8.1.3.2. Neurothrombectomy Devices
8.1.3.3. Carotid Artery Stents
8.1.3.4. Embolic Coils
8.1.3.5. Support Devices
8.1.4. Cerebrospinal Fluid Management Devices
8.1.4.1. CSF Shunt Devices
8.1.4.2. CSF Drainage Devices
8.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Hospitals
8.2.2. Ambulatory surgery centers
8.2.3. Neurology clinics
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028
8.5. North America Neurology Devices Market Dynamics – Trends
9. Europe Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
9.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Neurostimulation Devices
9.1.1.1. Spinal Cord Stimulation Devices
9.1.1.2. Deep Brain Stimulation Devices
9.1.1.3. Sacral Nerve Stimulation Devices
9.1.1.4. Other Neurostimulation Devices
9.1.2. Neurosurgery Devices
9.1.2.1. Neuroendoscopes
9.1.2.2. Stereotactic Systems
9.1.2.3. Aneurysm Clips
9.1.2.4. Other Neurosurgery Devices
9.1.3. Interventional Neurology Devices
9.1.3.1. Interventional/Surgical Simulators
9.1.3.2. Neurothrombectomy Devices
9.1.3.3. Carotid Artery Stents
9.1.3.4. Embolic Coils
9.1.3.5. Support Devices
9.1.4. Cerebrospinal Fluid Management Devices
9.1.4.1. CSF Shunt Devices
9.1.4.2. CSF Drainage Devices
9.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospitals
9.2.2. Ambulatory surgery centers
9.2.3. Neurology clinics
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028
9.5. Europe Neurology Devices Market Dynamics – Trends
10. Asia-Pacific Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
10.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Neurostimulation Devices
10.1.1.1. Spinal Cord Stimulation Devices
10.1.1.2. Deep Brain Stimulation Devices
10.1.1.3. Sacral Nerve Stimulation Devices
10.1.1.4. Other Neurostimulation Devices
10.1.2. Neurosurgery Devices
10.1.2.1. Neuroendoscopes
10.1.2.2. Stereotactic Systems
10.1.2.3. Aneurysm Clips
10.1.2.4. Other Neurosurgery Devices
10.1.3. Interventional Neurology Devices
10.1.3.1. Interventional/Surgical Simulators
10.1.3.2. Neurothrombectomy Devices
10.1.3.3. Carotid Artery Stents
10.1.3.4. Embolic Coils
10.1.3.5. Support Devices
10.1.4. Cerebrospinal Fluid Management Devices
10.1.4.1. CSF Shunt Devices
10.1.4.2. CSF Drainage Devices
10.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hospitals
10.2.2. Ambulatory surgery centers
10.2.3. Neurology clinics
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028
10.5. Asia-Pacific Neurology Devices Market Dynamics – Trends
11. Latin America Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
11.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Neurostimulation Devices
11.1.1.1. Spinal Cord Stimulation Devices
11.1.1.2. Deep Brain Stimulation Devices
11.1.1.3. Sacral Nerve Stimulation Devices
11.1.1.4. Other Neurostimulation Devices
11.1.2. Neurosurgery Devices
11.1.2.1. Neuroendoscopes
11.1.2.2. Stereotactic Systems
11.1.2.3. Aneurysm Clips
11.1.2.4. Other Neurosurgery Devices
11.1.3. Interventional Neurology Devices
11.1.3.1. Interventional/Surgical Simulators
11.1.3.2. Neurothrombectomy Devices
11.1.3.3. Carotid Artery Stents
11.1.3.4. Embolic Coils
11.1.3.5. Support Devices
11.1.4. Cerebrospinal Fluid Management Devices
11.1.4.1. CSF Shunt Devices
11.1.4.2. CSF Drainage Devices
11.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hospitals
11.2.2. Ambulatory surgery centers
11.2.3. Neurology clinics
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Neurology Devices Market – Opportunity Analysis Index, By Product, By End User and Country, 2022 – 2028
11.5. Latin America Neurology Devices Market Dynamics – Trends
12. Middle East and Africa Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
12.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Neurostimulation Devices
12.1.1.1. Spinal Cord Stimulation Devices
12.1.1.2. Deep Brain Stimulation Devices
12.1.1.3. Sacral Nerve Stimulation Devices
12.1.1.4. Other Neurostimulation Devices
12.1.2. Neurosurgery Devices
12.1.2.1. Neuroendoscopes
12.1.2.2. Stereotactic Systems
12.1.2.3. Aneurysm Clips
12.1.2.4. Other Neurosurgery Devices
12.1.3. Interventional Neurology Devices
12.1.3.1. Interventional/Surgical Simulators
12.1.3.2. Neurothrombectomy Devices
12.1.3.3. Carotid Artery Stents
12.1.3.4. Embolic Coils
12.1.3.5. Support Devices
12.1.4. Cerebrospinal Fluid Management Devices
12.1.4.1. CSF Shunt Devices
12.1.4.2. CSF Drainage Devices
12.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hospitals
12.2.2. Ambulatory surgery centers
12.2.3. Neurology clinics
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028
12.5. MEA Neurology Devices Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Abbott Laboratories
13.2.2. B. BRAUN MELSUNGEN AG
13.2.3. Boston Scientific Corporation
13.2.4. Sanofi
13.2.5. Integra LifeSciences Holdings Corporation
13.2.6. Johnson & Johnson
13.2.7. LivaNova PLC
13.2.8. Medtronic Plc
13.2.9. Magstim Co Ltd.
13.2.10. Penumbra, Inc.
13.2.11. Stryker Corporation
14. Research Methodology
15. Key Assumptions and Acronyms

Report

Company Profile

  • Abbott Laboratories
  • BRAUN MELSUNGEN AG
  • Boston Scientific Corporation
  • Sanofi
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic Plc
  • Magstim Co Ltd.
  • Penumbra, Inc.
  • Stryker Corporation

Description

Neurology Devices Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product, end user and region. This report studies global neurology devices market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global neurology devices market report includes human demographics; and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include, marketers, policymakers, and cold plasma service providers engaged. Neurological devices can help analyze, forestall, and treat an assortment of neurological issue and conditions, for example, Alzheimer’s sickness, Parkinson’s infection, significant dejection, epilepsy, spinal string damage, and horrendous mind damage. Neurological devices can be utilized to help reestablish hearing and locate and give expanded capacity to those with appendage misfortune or intrinsic appendage contrasts. Cases of neurological devices incorporate neurodiagnostics, neurointerventional, and neurostimulation devices. The expanding financing for R&D in the market will be one of the most recent patterns that will pick up footing in the interventional neurology devices market amid the following four years. The expanding subsidizing by government into R&D tasks and joint effort of government and non-government offices will support the market development.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX